TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Annovis Announces Two Presentations at the CTAD 2025 Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Maria Maccecchini, Ph.D.
Annovis Announces Two Presentations at the CTAD 2025 Conference

Annovis Bio will present two research presentations at the CTAD conference, highlighting biomarker data for buntanetap in treating Alzheimer's and Parkinson's diseases, focusing on potential disease-modifying therapeutic approaches.

Insights
ANVS   positive

Company is presenting promising research data suggesting potential breakthrough in treating neurodegenerative diseases, with biomarkers indicating potential efficacy of their drug buntanetap in addressing cognitive decline